Sep 18, 2020-Friday

select city

Metro cities - Delhi, Mumbai, Chennai, Kolkata

Other cities - Noida, Gurgaon, Bengaluru, Hyderabad, Bhopal , Chandigarh , Dehradun, Indore, Jaipur, Lucknow, Patna, Ranchi

Friday, Sep 18, 2020

Zydus cadila

Aug 18, 2020 23:19
The two Covid-19 vaccine candidates that are in phase I/II human trials are drug maker Zydus Cadila’s ZyCov-D and Bharat Biotech’s Covaxin. read more
Aug 18, 2020 00:11
The national vaccine expert group has referred the matter of selection of the right vaccine candidate for use in the country to the Standing Technical Sub-Committee of National Technical Advisory Group on Immunization (NTAGI). read more
Aug 16, 2020 23:45
According to an official, the National Expert Group on Vaccine Administration will hold its second meeting on Monday and discuss with granular details of Covid-19 vaccine procurement processes and pricing with the heads of several pharma firms, including SII, Bharat Biotech and Zydus Cadila read more
Aug 16, 2020 00:13
Indian biotech companies have developed two of the three vaccine candidates that have entered the human trial stage in India. read more
Aug 05, 2020 23:50
The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies conducted on animals. The vaccine was able to elicit a high level of neutralizing antibodies in animal studies. read more
Aug 05, 2020 13:58
The company will now start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers from Thursday to test its effectiveness, it said in a regulatory filing. read more
Aug 04, 2020 22:14
Addressing a press briefing, he said once a safe and effective vaccine is developed, the focus should be on prioritisation and its fair distribution, roll-out and cold chain logistics, stockpiling and training of people who would be administering the vaccine. read more
Jul 25, 2020 08:20
Bharat Biotech and Zydus were granted permission for Phase I and II clinical trials of Covaxin and ZyCoV-D respectively and the pharmaceutical companies have said the first doses of their vaccine candidates were administered to volunteers on July 15. read more
Jul 20, 2020 09:00
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on Covid-19 vaccines in India. read more
Jul 18, 2020 04:06
The company had on Wednesday started clinical trials of its Covid-19 vaccine candidate with the first human dosing. read more
Jul 15, 2020 23:44
No safety concerns were observed for the Covid-19 vaccine candidate, ZyCoV-D, in repeat-dose toxicology studies, according to the details shared by the company. read more
Jul 07, 2020 10:33
ICMR had written to 12 institutes where human trials are to be held for the vaccine, Covaxin, ordering them to secure necessary approvals from internal committees and recruit people for clinical tests by July 7 read more
Jul 04, 2020 09:17
The number of cases of the coronavirus disease in India is more than 625,000 and the country’s death toll is above 18,000. read more
Jun 12, 2020 20:33
Remdesivir, the investigational drug from Gilead Sciences Inc, has been issued an ‘emergency use authorisation’ (EUA) by the United States Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of coronavirus, Zydus Cadila said in a statement. read more